MFS
CADL icon

Mirabella Financial Services’s Candel Therapeutics CADL Stock Holding History

Mirabella Financial Services’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,489
Closed -$61.2K – 751
2026
Q1 		$61.2K Buy
+12,489
New +$68K 0.01% 880

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mirabella Financial Services's CADL Position: Q2 2026 in Review

Mirabella Financial Services sold out of Candel Therapeutics (CADL) in Q2 2026, closing a stake of 12,489 shares — an estimated $61.2K sold.

Mirabella Financial Services first reported a position in CADL in Q1 2026 and held it in 1 quarter. The position peaked at $61.2K in Q1 2026. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Mirabella Financial Services reported no remaining Candel Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Mirabella Financial Services sold 12,489 Candel Therapeutics shares in Q2 2026, an estimated $61.2K.
  • Mirabella Financial Services first reported a position in Candel Therapeutics in Q1 2026 and held it in 1 quarter.
  • Mirabella Financial Services's Candel Therapeutics position peaked at $61.2K in Q1 2026.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Mirabella Financial Services's 13F filing for Q2 2026, filed 31 Jul 2026.